Colony Stimulating Factors News and Research

RSS
Experimental Chinese SARS-CoV-2 vaccine appears safe in early trials

Experimental Chinese SARS-CoV-2 vaccine appears safe in early trials

Progression and severity of COVID-19 highly dependant on cytokine changes

Progression and severity of COVID-19 highly dependant on cytokine changes

FDA approves first Neulasta biosimilar to help decrease infection risk during cancer treatment

FDA approves first Neulasta biosimilar to help decrease infection risk during cancer treatment

Study: Use of white blood cell boosting drugs found to be safe during chemo-radiotherapy of lung cancer

Study: Use of white blood cell boosting drugs found to be safe during chemo-radiotherapy of lung cancer

Autologous haematopoietic stem cell transplantation promise for myasthenia gravis

Autologous haematopoietic stem cell transplantation promise for myasthenia gravis

Three researchers recognised for their contributions to Australian medical research

Three researchers recognised for their contributions to Australian medical research

PCORI funds five patient-centered comparative effectiveness research studies

PCORI funds five patient-centered comparative effectiveness research studies

Experience shows in febrile neutropenia treatment

Experience shows in febrile neutropenia treatment

CEL-SCI's Multikine cancer drug receives key Japanese patent

CEL-SCI's Multikine cancer drug receives key Japanese patent

Child who received first stem cell trachea transplant functioning well two years on

Child who received first stem cell trachea transplant functioning well two years on

Clinical results for Teva's biologic oncology candidates presented at MASCC/ISOO 2012

Clinical results for Teva's biologic oncology candidates presented at MASCC/ISOO 2012

GMCSF linked with rapid cognitive recovery in patients with cancer

GMCSF linked with rapid cognitive recovery in patients with cancer

Two new cancer research laboratories at WEHI receive $2M ACRF funding

Two new cancer research laboratories at WEHI receive $2M ACRF funding

CEL-SCI receives Chinese patent for Multikine cancer drug

CEL-SCI receives Chinese patent for Multikine cancer drug

Cellerant commences CLT-008 Phase I/II trial in patients with leukemia

Cellerant commences CLT-008 Phase I/II trial in patients with leukemia

Cancer patients continue to be affected by FN as a result of chemotherapy: Survey

Cancer patients continue to be affected by FN as a result of chemotherapy: Survey

New biosensor device may help in combating cancer

New biosensor device may help in combating cancer

Multikine treatment increases survival in cancer patients

Multikine treatment increases survival in cancer patients

Stimulating innate immunity helps ease Crohn's disease symptoms

Stimulating innate immunity helps ease Crohn's disease symptoms

Half of patients with aggressive non-Hodgkin's lymphoma fail to receive the recommended dose and schedule of chemotherapy

Half of patients with aggressive non-Hodgkin's lymphoma fail to receive the recommended dose and schedule of chemotherapy